Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim

被引：0
作者：
Tomonori Nakazato
Chisako Ito
Ai Mihara
Yoshinobu Aisa
机构：
[1] Yokohama Municipal Citizen’s Hospital,Department of Hematology
来源：
International Journal of Hematology | 2013年 / 97卷
关键词：
Platelet Count; Danazol; Romiplostim; Eltrombopag; Immune Thrombocytopenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 293
页数：2
相关论文
共 50 条
  • [41] Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment
    Ignatova, Anastasia A.
    Demina, Irina A.
    Ptushkin, Vadim V.
    Khaspekova, Svetlana G.
    Shustova, Olga N.
    Pankrashkina, Maria M.
    Ryabykh, Aleksandr A.
    Obydennyi, Sergei I.
    Strelkova, Olga S.
    Polokhov, Dmitry M.
    Seregina, Elena A.
    Poletaev, Aleksandr V.
    Ataullakhanov, Fazoil I.
    Kireev, Igor I.
    Mazurov, Alexei V.
    Maschan, Alexei A.
    Novichkova, Galina A.
    Panteleev, Mikhail A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : E38 - E42
  • [42] Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
    Tremblay, Gabriel
    Dolph, Mike
    Bhor, Menaka
    Said, Qayyim
    Elliott, Brian
    Briggs, Andrew
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 705 - 713
  • [43] Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment
    Semple, John W.
    Schifferli, Alexandra
    Cooper, Nichola
    Saad, Hossam
    Mytych, Daniel T.
    Chea, Lynette S.
    Newland, Adrian
    BLOOD REVIEWS, 2024, 67
  • [44] Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant
    Chiba, Yuko
    Tasaka, Keiji
    Matsubara, Kousaku
    Mori, Makiko
    Muraoka, Michiko
    Hamabata, Takayuki
    Nodomi, Seishiro
    Waki, Kenji
    PEDIATRIC BLOOD & CANCER, 2024, 71 (06)
  • [45] Treatment of chronic immune thrombocytopenia in children with romiplostim
    Chaturvedi, Shruti
    McCrae, Keith R.
    LANCET, 2016, 388 (10039) : 4 - 6
  • [46] Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag
    Chouhan, Jyoti D.
    Herrington, Jon D.
    PHARMACOTHERAPY, 2010, 30 (07): : 666 - 683
  • [47] Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity
    Janssens, Ann
    Tarantino, Michael
    Bird, Robert J.
    Mazzucconi, Maria Gabriella
    Boccia, Ralph V.
    Lopez Fernandez, Maria Fernanda
    Kozak, Tomas
    Steurer, Michael
    te Boekhorst, Peter
    Dillingham, Kerry
    Kreuzbauer, Georg
    Woodard, Paul
    ACTA HAEMATOLOGICA, 2015, 134 (04) : 215 - 228
  • [48] Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland
    Lee D.
    Thornton P.
    Hirst A.
    Kutikova L.
    Deuson R.
    Brereton N.
    Applied Health Economics and Health Policy, 2013, 11 (5) : 457 - 469
  • [49] Outcomes of Eltrombopag Treatment and Development of Iron Deficiency in Children with Immune Thrombocytopenia in Turkey
    Yozgat, Ayca Koca
    Leblebisatan, Goksel
    Akbayram, Sinan
    Ozel, Simge Cinar
    Karakas, Zeynep
    Erduran, Erol
    Yilmaz, Sebnem
    Kocak, Ulker
    Unal, Sule
    Ozdemir, Gul Nihal
    Albayrak, Meryem
    Zengin, Emine
    Oymak, Yesim
    Bor, Ozcan
    Cakmakli, Hasan Fatih
    Soker, Murat
    Gokcebay, Dilek Gurlek
    Tokgoz, Huseyin
    Malbora, Baris
    Karaman, Serap
    Celkan, Tiraje
    Sasmaz, Ilgen
    Yarali, Nese
    Oren, Hale
    Unuvar, Aysegul
    Ozbek, Namik Yasar
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (03) : 139 - 144
  • [50] Is There a Role for Low-Dose Eltrombopag as Maintenance Therapy in the Treatment of Immune Thrombocytopenia?
    Vlachaki, Efthymia
    Sousos, Nikolaos
    Perifanis, Vasilios
    Kaiafa, Georgia
    Onoufriadis, Ilias
    Hatzitolios, Apostolos
    Boura, Panagiota
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 78 - 82
12345